FDA cleared platform PinMed offers an FDA-cleared cloud-based mobile monitoring platform and analytical software, presenting a ready-to-sell healthcare solution that can be positioned to hospitals, clinics, and clinical research organizations seeking compliant, scalable cardiovascular monitoring and study analytics.

Niche cardiovascular analytics The company focuses on tracking subtle longitudinal cardiovascular changes, enabling sales conversations with cardiology departments, heart clinics, and research teams pursuing early detection capabilities and real-world evidence generation.

Strategic partnerships Existing collaboration with National Marine Mammal Foundation under a U.S. Navy contract signals potential for defense, research, and specialized medical programs, opening doors to government bids and sponsored research opportunities.

Early-stage growth opportunity With revenue under $1M and 0-1 employees, PinMed presents a prospects case for enterprise-level partnerships, potential OEM collaborations, and white-label licensing to scale technology through larger medical device or health IT players.

Cloud and dev stack Utilizing AWS, Ruby on Rails, GitHub, and modern web tools indicates a modern, scalable tech foundation suitable for integration with existing hospital information systems, EHR/EMR platforms, and data lakes for joint selling with larger healthcare IT vendors.